Skip to content
10-Q

Quarterly Report

BALCHEM CORP BCPC

0001628280-25-019593

← back to feed
Filed
Apr 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 17, 2025 32.62M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $49.9M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $49.52M
Current Liabilities Q1 2025 · Mar 31, 2025 $139.56M
Current Liabilities Q1 2025 · Dec 31, 2024 $157.69M
Total Liabilities Q1 2025 · Mar 31, 2025 $408.85M
Total Liabilities Q1 2025 · Dec 31, 2024 $425.46M
Current Assets Q1 2025 · Mar 31, 2025 $340.24M
Current Assets Q1 2025 · Dec 31, 2024 $313.77M
Total Assets Q1 2025 · Mar 31, 2025 $1.62B
Total Assets Q1 2025 · Dec 31, 2024 $1.58B
Shares Diluted Q1 2025 · Mar 31, 2024 32.63M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $5.2M
Dividends Paid Q1 2025 · Mar 31, 2024 $25.56M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $33.39M
Stockholders Equity Q1 2025 · Mar 31, 2024 $1.08B
Stockholders Equity Q1 2025 · Dec 31, 2023 $1.05B
Eps Diluted Q1 2025 · Mar 31, 2024 $0.89
Eps Basic Q1 2025 · Mar 31, 2024 $0.90
Rd Expense Q1 2025 · Mar 31, 2024 $4.1M
Net Income Q1 2025 · Mar 31, 2024 $28.99M
Operating Income Q1 2025 · Mar 31, 2024 $41.68M
Gross Profit Q1 2025 · Mar 31, 2024 $81.51M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $158.15M
Revenue Q1 2025 · Mar 31, 2024 $239.66M